$5096 | SAVE $899 | Single User
$10192 | SAVE $1,798 | Site License
$15287 | SAVE $2,698 | Enterprise License

MediPoint: Renal Denervation - Global Analysis and Market Forecasts

MediPoint: Renal Denervation - Global Analysis and Market Forecasts
[Lowest Price Guaranteed: $5,096]

Published by Global Data: 01 Apr 2016 | 26880 | In Stock
Related Topics: Medical

Introduction

MediPoint: Renal Denervation - Global Analysis and Market Forecasts

Summary

Renal denervation catheters are categorized into the following: radiofrequency (RF) catheters, ultrasound catheters, and micro-injection catheters.

Growth in the renal denervation market will be driven primarily by a need for a new intervention to treat resistant hypertension.

This technology has the potential to revolutionize the cardiac field, providing a minimally invasive solution where none currently exist.

The global market for renal denervation devices is dominated by Medtronic, St. Jude Medical, and Boston Scientific.

Other key players include Cordis, ReCor Medical, and Terumo

Highlights

Key Questions Answered

- What is the current and future renal denervation market outlook in the developed and emerging markets? What trends and events are affecting the global market?

- Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products?

- What are the unmet needs with the current generation of devices ? How will emerging technologies such as the next generation radiofrequency and ultrasound catheters and new micro-injection catheters fulfill these unmet needs?

- How will current and future clinical trials affect the market? When are new devices expected to commercialize?

- What are the challenges and complications that have hindered widespread adoption?

- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global peripheral vascular interventions market?

Scope

- Competitive assessment: Currently marketed renal denervation products and evolving competitive landscape

- In-depth analysis of unmet needs and adoption trends of different renal denervation devices

- Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications

- Pipeline analysis: Emerging products and technologies.

- Annualized total renal denervation diagnostics market revenue by segment and market outlooks by country from 2012-2022.

- Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

Reasons to buy

The report will enable you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global renal denervation market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global renal denervation market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Track device sales in the global and country-specific renal denervation market from 2012-2022.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents
for MediPoint: Renal Denervation - Global Analysis and Market Forecasts

  • 1 Table of Contents

    1 Table of Contents 6

    1.1 List of Tables 9

    1.2 List of Figures 11

    2 Introduction 13

    2.1 Catalyst 15

    2.2 Related Reports 16

    3 Market Access 17

    3.1 The Symplicity HTN-3 Trial 17

    3.2 Reimbursement 18

    3.2.1 Europe 18

    3.2.2 Russia 18

    3.2.3 Australia 19

    3.3 M&A/Key Partnerships 19

    3.3.1 The Cardinal Health Acquisition of Cordis 20

    3.3.2 The Boston Scientific Acquisition of Vessix Vascular 20

    3.3.3 The Medtronic Acquisition of Ardian 20

    4 Unmet Needs 21

    4.1 Overview 21

    4.2 Nerve Regeneration 21

    4.3 Ambulatory Blood Pressure Readings 21

    4.4 Expanded Indications for the Use of Renal Denervation 22

    4.5 Intervention to Monitor Treatment Progress 25

    4.6 Long-Term Effects 25

    5 Competitive Assessment 26

    5.1 Company Share Analysis 26

    5.2 Major Players 27

    5.2.1 Ablative Solutions 27

    5.2.2 Boston Scientific 29

    5.2.3 CardioSonic 31

    5.2.4 Cordis Corporation 33

    5.2.5 Kona Medical 34

    5.2.6 Medtronic 36

    5.2.7 ReCor Medical 39

    5.2.8 Renal Dynamics 41

    5.2.9 St. Jude Medical 42

    5.2.10 Terumo 44

    5.3 Emerging Players 47

    6 Market Outlooks 48

    6.1 Procedure Trends 48

    6.2 Market Drivers and Barriers 51

    6.2.1 Market Driver 1: Large Disease Prevalence 51

    6.2.2 Market Driver 2: Expanding Indications 51

    6.2.3 Market Barrier 1: Dependency on Clinical Trials 52

    6.2.4 Market Barrier 2: Reimbursement 52

    6.2.5 Market Barrier 3: Development of Competing Technology 53

    6.3 Market Outlooks by Segment 53

    6.3.1 Radiofrequency Catheters 54

    6.3.2 Ultrasound Catheters 55

    6.3.3 Micro-infusion Catheters 56

    6.4 Market Outlooks by Geography 57

    6.4.1 North America 58

    6.4.2 Europe 62

    6.4.3 Asia-Pacific 70

    6.4.4 South America 77

    7 Appendix 79

    7.1 Bibliography 79

    7.2 Abbreviations 86

    7.3 Methodology 87

    7.3.1 Overview 87

    7.3.2 Coverage 87

    7.4 Forecasting Methodology 88

    7.4.1 Overview 88

    7.4.2 Patient Population 88

    7.4.3 Procedure Volume by Type of Disease 88

    7.4.4 Procedure Volume by Type of Device 88

    7.4.5 Average Selling Price 88

    7.5 Primary Research Efforts 89

    7.6 About the Authors 90

    7.6.1 Brigitte Babin, MSc, Analyst, Medical Devices 90

    7.6.2 Linda Tian, MSc, Managing Analyst, Medical Devices 90

    7.6.3 Tyler Fletcher, BSc, Global Head of Medical Devices 90

    7.7 About GlobalData 91

    7.8 Disclaimer 91

List Of Tables
in MediPoint: Renal Denervation - Global Analysis and Market Forecasts

1.1 List of Tables

Table 1: Mergers and Acquisitions/Key Partnership 20

Table 2: Clinical Trials Currently Underway Assessing Other Indications for Renal Denervation 23

Table 3: Key Clinical Trials Assessing Other Indications for Renal Denervation 24

Table 4: Company Profile - Ablative Solutions Inc. 27

Table 5: Ablative Solutions - SWOT Analysis, 2016 28

Table 6: Company Profile - Boston Scientific 29

Table 7: Boston Scientific - SWOT Analysis, 2016 29

Table 8: Product Profile - Vessix Renal Denervation System 30

Table 9: Company Profile - CardioSonic Inc. 31

Table 10: CardioSonic. - SWOT Analysis, 2016 31

Table 11: Product Profile - TIVUS Renal Denervation System 32

Table 12: Company Profile - Cordis Corporation 33

Table 13: Cordis - SWOT Analysis, 2016 33

Table 14: Product Profile - RENLANE Renal Denervation System 34

Table 15: Company Profile - Kona Medical Inc. 35

Table 16: Kona Medical Inc. - SWOT Analysis, 2016 35

Table 17: Company Profile - Medtronic 36

Table 18: Medtronic - SWOT Analysis, 2016 37

Table 19: Product Profile - Symplicity Flex Renal Denervation Catheter 37

Table 20: Product Profile - Symplicity Spyral Renal Denervation Catheter 38

Table 21: Company Profile - ReCor Medical Inc. 39

Table 22: ReCor Medical, Inc. - SWOT Analysis, 2015 39

Table 23: Product Profile - Paradise Renal Denervation System 40

Table 24: Company Profile - Renal Dynamics 41

Table 25: Renal Dynamics - SWOT Analysis, 2015 41

Table 26: Product Profile - ReDy Renal Denervation System 42

Table 27: Company Profile - St. Jude Medical 42

Table 28: St. Jude Medical - SWOT Analysis, 2016 43

Table 29: Product Profile - EnligHTN Renal Denervation System 44

Table 30: Company Profile - Terumo 45

Table 31: Terumo - SWOT Analysis, 2016 45

Table 32: Product Profile - Iberis Rrenal Denervation System 46

Table 33: Summary of Emerging Players and Associated Renal Denervation Technologies 47

Table 34: Global Radiofrequency Catheter - Renal Denervation Sales ($m) Forecast, 2012-2022 55

Table 35: Global Ultrasound Catheter - Renal Denervation Sales ($m) Forecast, 2012-2022 56

Table 36: Micro-Infusion Catheter clinical trials 57

Table 37: Canada Renal Denervation Sales ($m) Forecast, 2012-2022 59

Table 38: Mexico Renal Denervation Sales ($m) Forecast, 2012-2022 61

Table 39: US Renal Denervation Sales ($m) Forecast, 2012-2022 62

Table 40: France Renal Denervation Sales ($m) Forecast, 2012-2022 64

Table 41: Germany Renal Denervation Sales ($m) Forecast, 2012-2022 65

Table 42: Italy Renal Denervation Sales ($m) Forecast, 2012-2022 66

Table 43: Russia Renal Denervation Sales ($m) Forecast, 2012-2022 67

Table 44: Spain Renal Denervation Sales ($m) Forecast, 2012-2022 68

Table 45: UK Renal Denervation Sales ($m) Forecast, 2012-2022 69

Table 46: Australia Renal Denervation Sales ($m) Forecast, 2012-2022 72

Table 47: China Renal Denervation Sales ($m) Forecast, 2012-2022 73

Table 48: India Renal Denervation Sales ($m) Forecast, 2012-2022 74

Table 49: Japan Renal Denervation Sales ($m) Forecast, 2012-2022 75

Table 50: South Korea Renal Denervation Sales ($m) Forecast, 2012-2022 76

Table 51: Brazil Renal Denervation Sales ($m) Forecast, 2012-2022 77

List Of Figures, Charts and Diagrams
in MediPoint: Renal Denervation - Global Analysis and Market Forecasts

1.2 List of Figures

Figure 1: Steps Required Prior to Treatment with Renal Denervation 14

Figure 2: Global Company Share Analysis - Renal Denervation 26

Figure 3: Vessix V2 Renal Denervation Catheter 30

Figure 4: RENLANE Renal Denervation Catheter 34

Figure 5: Surround Sound Renal Denervation System 36

Figure 6: Symplicity Spyral Renal Denervation Catheter 38

Figure 7: Paradise Ultrasound Renal Denervation Catheter 40

Figure 8: EnligHTN Renal Denervation System 43

Figure 9: Composition of Global Renal Denervation by Procedure Volumes, 2015 and 2022 49

Figure 10: Global Renal Denervation Market Value ($m) - High-, Mid-, and Low-Level Predictive Adoption Models, 2012-2022 51

Figure 11: Global Renal Denervation Procedure Volume Forecast, 2012-2022 54

Figure 12: Comparison of Major Geography Segments, 2012-2022 58

Figure 13: North American Renal Denervation Procedure Volume, 2012-2022 59

Figure 14: Canada Renal Denervation Sales ($m) Forecast, 2012-2022 60

Figure 15: Mexico Renal Denervation Sales ($m) Forecast, 2012-2022 61

Figure 16: US Renal Denervation Sales ($m) Forecast, 2012-2022 62

Figure 17: European Renal Denervation Procedure Volume, 2012-2022 63

Figure 18: France Renal Denervation Sales ($m) Forecast, 2012-2022 64

Figure 19: Germany Renal Denervation Sales ($m) Forecast, 2012-2022 65

Figure 20: Italy Renal Denervation Sales ($m) Forecast, 2012-2022 66

Figure 21: Russia Renal Denervation Sales ($m) Forecast, 2012-2022 67

Figure 22: Spain Renal Denervation Sales ($m) Forecast, 2012-2022 69

Figure 23: UK Renal Denervation Sales ($m) Forecast, 2012-2022 70

Figure 24: APAC Renal Denervation Market Value, 2012-2022 71

Figure 25: Australia Renal Denervation Sales ($m) Forecast, 2012-2022 72

Figure 26: China Renal Denervation Sales ($m) Forecast, 2012-2022 73

Figure 27: India Renal Denervation Sales ($m) Forecast, 2012-2022 74

Figure 28: Japan Renal Denervation Sales ($m) Forecast, 2012-2022 75

Figure 29: South Korea Renal Denervation Sales ($m) Forecast, 2012-2022 76

Figure 30: Brazil Renal Denervation Sales ($m) Forecast, 2012-2022 78

Figure 31: Survey Breakdown by Profession 89

Additional Details

Publisher

Global Data

Publisher Information

Reference

26880 | GDME0226MAR

Number of Pages

92

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! MediPoint: Contrast Media Injectors - Global Analysis and Market Forecasts
MediPoint: Contrast Media Injectors - Global Analysis and Market ForecastsSummaryContrast media inje...
01 May 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Biopsy Devices - Global Analysis and Market Forecasts
MediPoint: Biopsy Devices - Global Analysis and Market ForecastsSummaryCancer is the uncontrolled gr...
01 Apr 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Renal Denervation - Global Analysis and Market Forecasts
MediPoint: Renal Denervation - Global Analysis and Market ForecastsSummaryRenal denervation catheter...
01 Apr 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Contrast Media - Global Analysis and Market Forecasts
MediPoint: Contrast Media - Global Analysis and Market ForecastsSummaryContrast media are a group of...
01 Apr 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts
MediPoint: Peripheral Vascular Interventions - Global Analysis and Market ForecastsSummaryThe periph...
14 Mar 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts
MediPoint: Point of Care Diagnostics - Global Analysis and Market ForecastsSummaryPoint-of-care test...
01 Mar 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Electrosurgical Devices - Global Analysis and Market Forecasts
MediPoint: Electrosurgical Devices - Global Analysis and Market ForecastsSummaryElectrosurgical gene...
01 Mar 2016 by Global Data USD $5,096 (normally
USD $5,995)
More Info
SAVE 15% today! MediPoint: Women’s Health - Global Analysis and Market Forecasts
MediPoint: Women’s Health - Global Analysis and Market ForecastsSummaryThe women’s health medical de...
01 Nov 2015 by Global Data USD $5,521 (normally
USD $6,495)
More Info
SAVE 15% today! MediPoint: Endoscopy - Global Analysis and Market Forecasts
MediPoint: Endoscopy - Global Analysis and Market ForecastsSummaryThe global endoscopy market is a d...
01 Nov 2015 by Global Data USD $5,521 (normally
USD $6,495)
More Info
SAVE 15% today! MediPoint: Compression Therapy - Global Analysis and Market Forecasts
MediPoint: Compression Therapy - Global Analysis and Market ForecastsSummaryCompression therapy prod...
01 Oct 2015 by Global Data USD $5,521 (normally
USD $6,495)
More Info

This report is published by Global Data

Download Free Report Summary PDF

MediPoint: Renal Denervation - Global Analysis and Market Forecasts | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...